ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.

Property Value
dbo:abstract
  • ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. An ImmunoGen ADC contains a manufactured antibody that binds to a target found on cancer cells, with one of the company's potent cell-killing agents attached as a "payload". The antibody serves to deliver the cell-killing agent specifically to cancer cells bearing its target and the payload serves to kill these cells. In some cases, the antibody also has anticancer activity. (en)
dbo:industry
dbo:numberOfEmployees
  • 296 (xsd:integer)
dbo:type
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2020-01-22 05:29:45Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 42153115 (xsd:integer)
dbo:wikiPageLength
  • 7050 (xsd:integer)
dbo:wikiPageModified
  • 2020-01-22 05:29:42Z (xsd:date)
dbo:wikiPageOutDegree
  • 59 (xsd:integer)
dbo:wikiPageRevisionID
  • 936979448 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. (en)
rdfs:label
  • ImmunoGen (en)
owl:sameAs
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • ImmunoGen Inc. (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of